-
Sulfamonomethoxine: From DHPS to Translation
2026-09-22
Sulfamonomethoxine is more than a veterinary antimicrobial benchmark: its DHPS mechanism, formulation constraints, pharmacokinetic context, and environmental fate create a practical framework for translational research. This article connects SMM efficacy studies with residue assessment, aquatic safety, and biotransformation strategy.
-
CPI-613 Workflows for Mitochondrial Assays
2026-09-21
Build reproducible tumor cell metabolism studies around CPI-613 by connecting mitochondrial energy disruption with ATP loss, membrane-potential changes, and apoptosis. This practical guide covers solvent handling, dose-response design, combination testing, mechanistic controls, and how the latest PDHA1–cuproptosis findings can inform—but not overstate—new assay hypotheses.
-
7-AAD Cell Viability Assay Kit for CAR-T
2026-09-21
The 7-AAD Cell Viability Assay Kit provides a membrane-integrity endpoint for distinguishing viable cells from necrotic and late-apoptotic populations in CAR-T experiments. Its red-shifted signal supports multiplex panels with FITC, PE, APC, Calcein AM, or Annexin V while helping researchers quantify target-cell killing and effector-cell fratricide.
-
E-4031: From hERG Blockade to 3D Arrhythmia Maps
2026-09-20
E-4031 is more than a conventional hERG assay control: paired with 3D cardiac organoids and shell microelectrode arrays, it can help connect IKr inhibition to spatially resolved conduction, repolarization, and arrhythmogenic phenotypes. This thought-leadership article outlines how translational researchers can use E-4031 to strengthen cardiac electrophysiology research while avoiding overinterpretation of organoid and QT-related data.
-
Sulfachloropyridazine: From Target to Microbiome
2026-09-19
Sulfachloropyridazine is a sulfonamide antibacterial agent for connecting DHPS inhibition with strain-level susceptibility and microbiome responses. This evidence-led guide shows how to choose assays, control solvent effects, and interpret ecological data without confusing biochemical potency with therapeutic outcome.
-
5-Fluorouracil (Adrucil): Assay Design
2026-09-19
Fluorouracil and 5-Fluorouracil are more than cytotoxicity benchmarks: they can reveal how nucleotide stress intersects with tumor-cell state. This guide connects thymidylate synthase inhibition with stemness-aware assay design, using gastric cancer research as a mechanistic framework without overstating translational evidence.
-
nPEC for Dual-Loaded Liposome Encapsulation
2026-09-18
Yuan and colleagues compared six approaches for measuring encapsulation efficiency in liposomes carrying hydrophilic and lipophilic drugs, using three dual-loaded formulations as test systems. Their validated nanoparticle exclusion chromatography method enabled simultaneous online HPLC analysis and offered a less formulation-dependent alternative to centrifugation, dialysis, ultrafiltration, and PEG-specific separation.
-
CUDC-907: PI3K/HDAC Workflow Guide
2026-09-18
CUDC-907 is a dual PI3K and HDAC inhibitor for controlled in vitro studies of PI3K/AKT signaling, protein acetylation, cell-cycle distribution, and apoptosis in cancer cell models. This guide translates the supplied product dossier into a practical workflow and defines handling limits; the compound is not intended for diagnostic, therapeutic, or clinical use.
-
Resazurin Sodium Salt for Cell Metabolism
2026-09-17
Resazurin sodium salt converts cellular redox activity into a red fluorescence signal that can support plate-based screening, microscopy, and flow analysis. This practical guide links assay design to the gut microbiota–GLP-1 findings while emphasizing solvent control, exposure timing, and interpretation limits.
-
Sulfo-NHS-SS-Biotin Protocol and QC Guide
2026-09-17
Sulfo-NHS-SS-Biotin provides a cleavable, water-compatible method for labeling accessible primary amines on proteins and intact-cell surfaces before avidin/streptavidin enrichment or detection. It is appropriate for fresh, short-duration conjugation workflows, but not for targets lacking accessible amines, prolonged storage in solution, or experiments that require the biotin label to remain intact under reducing conditions.
-
CCCP as a Mitochondrial Phenotype Stress Test
2026-09-16
CCCP (carbonyl cyanide m-chlorophenyl hydrazine) is more than an oxidative phosphorylation inhibitor: it can act as a controlled mitochondrial stressor for interpreting morphology and bioenergetic phenotypes. This article connects CCCP perturbation logic with deep-learning analysis of urine-derived stem cells in Alzheimer’s disease research.
-
NBC19 for Reliable NLRP3 Inflammasome Assays
2026-09-15
Learn how NBC19 (SKU BA6129) can support reproducible NLRP3 and IL-1β experiments alongside viability and cytotoxicity controls. This scenario-based guide connects product-reported potency with practical assay design, interpretation, storage, and vendor-selection decisions.
-
WY-14643: PPARα Workflows for Metabolic Research
2026-09-15
WY-14643 (Pirinixic Acid) is a practical pharmacological probe for connecting PPARα activation with lipid metabolism regulation, endothelial inflammation, and metabolic phenotypes. This guide translates multiomics findings in primary pulmonary lymphoepithelioma-like carcinoma into controlled dose-response, sample-preparation, and mechanism-validation workflows.
-
Ertugliflozin (PF-04971729) Experimental Workflow
2026-09-14
Build reproducible renal glucose transport, diabetes, inflammation, and cardiac ischemia workflows with the highly selective SGLT2 inhibitor Ertugliflozin. This guide translates comparative in vivo findings into practical dosing, assay-selection, formulation, and troubleshooting decisions.
-
7-Ethyl-10-hydroxycamptothecin in Cell Assays
2026-09-14
Build mechanism-resolved cancer assays with 7-Ethyl-10-hydroxycamptothecin (SN-38), combining topoisomerase I inhibition with cell-cycle and apoptosis measurements. This workflow also translates FUBP1/FUSE findings into practical assay choices for colon cancer and hepatocellular carcinoma research.